Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1713565rdf:typepubmed:Citationlld:pubmed
pubmed-article:1713565lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:1713565lifeskim:mentionsumls-concept:C0019189lld:lifeskim
pubmed-article:1713565lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:1713565lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:1713565lifeskim:mentionsumls-concept:C2697585lld:lifeskim
pubmed-article:1713565lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:1713565lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:1713565pubmed:issue2lld:pubmed
pubmed-article:1713565pubmed:dateCreated1991-8-30lld:pubmed
pubmed-article:1713565pubmed:abstractTextT lymphocyte-mediated cytolytic immune reactions are considered a major cause of hepatocyte injury in chronic viral and autoimmune hepatitis. To further investigate local immune responses, we studied the expression of lymphocyte antigens and cell-cell interaction molecules known to be involved in effector-target cell interactions by light and electron microscopy in liver biopsy specimens from patients with chronic viral and autoimmune hepatitis. CD8+ lymphocytes were found to be the predominant population of cells in the inflammatory infiltrate in chronic hepatitis B and non-A, non-B hepatitis. In contrast, CD4+ cells constituted a comparably higher proportion of cells and were more numerous than CD8+ cells in chronic autoimmune hepatitis. In both viral and autoimmune hepatitis, a substantial portion of lymphocytes expressed activation antigens such as T11/3 (CD2R) and IL-2-R (CD25). Lymphocyte function-associated antigen-3 (CD58), which mediates lymphocyte adhesion and activation and is the natural ligand of the CD2/T11 lymphocyte surface receptor, could be demonstrated on endothelial cells and hepatocytes. Hepatocellular lymphocyte function-associated antigen-3 expression in chronic hepatitis showed membranous and cytoplasmic staining of hepatocytes and had a positive correlation with the degree of inflammatory activity. These results suggest that effector-target interactions between hepatocytes and lymphocytes mediated by the lymphocyte function-associated antigen-3/CD2 pathway play a role in chronic inflammatory liver disease. Possible functional consequences of this interaction include enhancement of antigen-specific immune reactions and antigen-independent mechanisms of T cell activation, which may contribute considerably to the degree of inflammatory activity and tissue damage in chronic hepatitis.lld:pubmed
pubmed-article:1713565pubmed:languageenglld:pubmed
pubmed-article:1713565pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1713565pubmed:citationSubsetIMlld:pubmed
pubmed-article:1713565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1713565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1713565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1713565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1713565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1713565pubmed:statusMEDLINElld:pubmed
pubmed-article:1713565pubmed:monthAuglld:pubmed
pubmed-article:1713565pubmed:issn0270-9139lld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:ThoenenHHlld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:Meyer zum...lld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:HessGGlld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:DienesH PHPlld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:MannsMMlld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:MeuerS CSClld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:MoebiusUUlld:pubmed
pubmed-article:1713565pubmed:authorpubmed-author:AutschbachFFlld:pubmed
pubmed-article:1713565pubmed:issnTypePrintlld:pubmed
pubmed-article:1713565pubmed:volume14lld:pubmed
pubmed-article:1713565pubmed:ownerNLMlld:pubmed
pubmed-article:1713565pubmed:authorsCompleteYlld:pubmed
pubmed-article:1713565pubmed:pagination223-30lld:pubmed
pubmed-article:1713565pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:meshHeadingpubmed-meshheading:1713565-...lld:pubmed
pubmed-article:1713565pubmed:year1991lld:pubmed
pubmed-article:1713565pubmed:articleTitleHepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis.lld:pubmed
pubmed-article:1713565pubmed:affiliationInstitut für Pathologie, Johannes Gutenberg Universität, Mainz, Federal Republic of Germany.lld:pubmed
pubmed-article:1713565pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1713565pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1713565lld:pubmed